Bright Minds Biosciences (BMB) is an American pharmaceutical company which is developing serotonin 5-HT2 receptor agonists for potential medical use.
Drug candidates
Bright Minds Biosciences' drug candidates include the following: The company has also patented azepinoindoles acting as potent serotonin 5-HT2 receptor agonists and psychedelics, such as Pharm-136. ==See also==